Search

everythinglearnresearchcommunity

for

Search:↓

Green tea component EGCG may help prevent hair loss by changing microRNA levels in certain scalp cells.

Testosterone conversion to 5α-DHT may not be essential for its effects on the skin.

Hair loss drugs may cause sexual issues and infertility in men.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Certain natural compounds can block an enzyme linked to prostate enlargement and hair loss, showing potential for new treatments.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

Low dose finasteride decreases certain steroids, possibly increasing depression risk.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

Testosterone increases muscle mass regardless of DHT conversion blocking.

The discovery of 5α-reductase deficiency in guevedoces led to the development of important urologic medications.

Affected males are born with ambiguous genitalia, raised as females, but develop male traits at puberty due to enzyme deficiency.

High doses of cyclosporine A increase testosterone conversion, possibly boosting hair growth.

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

Hormone levels in hair vary across the head, with the highest concentration of a key hormone linked to hair loss at the top.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

A new method was created to test the effectiveness of Dihydrotestosterone (DHT) inhibitors, like finasteride and dutasteride, in human and fish cells. The results showed fish cells are more sensitive to these treatments, and dutasteride works better than finasteride in all tested cells.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Dihydrotestosterone can be made from dehydroepiandrosterone in skin cells without needing testosterone.

Researchers found four natural compounds that can change DHT levels in prostate cancer cells.

Compound 4 is a promising treatment for hair loss with low toxicity.

Epitestosterone may counteract testosterone's effects and has roles in body processes like prostate growth and hair distribution.

The procedure accurately measures 5-alpha-dihydrotestosterone in blood, useful for standard tests.

A 36-year-old person with a female appearance but male chromosomes was diagnosed with a rare enzyme deficiency affecting sexual development.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

ADT-G may be a useful indicator of increased androgen levels in women with acne and can be lowered with certain birth control pills.

Antiandrogens and finasteride may help treat excess hair and hair loss in women.

People with hair loss have different hormone levels, and these hormones can affect hair growth.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.